$7.58
0.111.47%
At close: -
$7.53
-0.05-0.66%
After Hours: 5:52 PM EDT
Comments
Loading...
10x Genomics Stock Guidance | NASDAQ:TXG | Benzinga
10x Genomics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/12/2025 | TXG | 10x Genomics | FY | 2025 | — | — | — | $610.00M | $630.00M | $630.36M | Get Alert |
| 01/13/2025 | TXG | 10x Genomics | FY | 2024 | — | — | — | $611.00M | $611.00M | $610.80M | Get Alert |
| 10/29/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $595.00M | $605.00M | $636.59M | Get Alert |
| 10/09/2024 | TXG | 10x Genomics | Q3 | 2024 | — | — | — | $151.70M | $151.70M | $162.24M | Get Alert |
| 08/08/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $640.00M | $660.00M | $663.06M | Get Alert |
| 04/30/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $670.00M | $690.00M | $677.79M | Get Alert |
| 02/15/2024 | TXG | 10x Genomics | FY | 2024 | — | — | — | $670.00M | $690.00M | $702.06M | Get Alert |
| 01/08/2024 | TXG | 10x Genomics | FY | 2023 | — | — | — | $618.70M | $618.70M | $614.69M | Get Alert |
| 01/08/2024 | TXG | 10x Genomics | Q4 | 2023 | — | — | — | $184.00M | $184.00M | $179.70M | Get Alert |
| 11/02/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $610.00M | $625.00M | $608.22M | Get Alert |
| 08/03/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $600.00M | $620.00M | $600.73M | Get Alert |
| 05/03/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $590.00M | $610.00M | $593.20M | Get Alert |
| 02/15/2023 | TXG | 10x Genomics | FY | 2023 | — | — | — | $580.00M | $600.00M | $613.96M | Get Alert |
| 11/02/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $500.00M | $520.00M | $509.87M | Get Alert |
| 08/08/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $500.00M | $520.00M | $571.06M | Get Alert |
| 07/14/2022 | TXG | 10x Genomics | Q2 | 2022 | — | — | — | $114.50M | $114.50M | $127.70M | Get Alert |
| 05/04/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $600.00M | $630.00M | $614.05M | Get Alert |
| 02/16/2022 | TXG | 10x Genomics | FY | 2022 | — | — | — | $600.00M | $630.00M | $679.87M | Get Alert |
| 11/03/2021 | TXG | 10x Genomics | FY | 2021 | — | — | — | $490.00M | $500.00M | $489.77M | Get Alert |
| 08/04/2021 | TXG | 10x Genomics | FY | 2021 | — | — | — | $480.00M | $500.00M | $496.49M | Get Alert |
| 05/05/2021 | TXG | 10x Genomics | FY | 2021 | — | — | — | $480.00M | $500.00M | $494.98M | Get Alert |
| 02/17/2021 | TXG | 10x Genomics | FY | 2021 | — | — | — | $480.00M | $500.00M | $494.02M | Get Alert |
FAQ
What is the most recent guidance for 10x Genomics (TXG)?
There have been no specific sales or earnings guidance reported for 10x Genomics in recent months.
Browse guidance and forecast on all stocks.